Back
Merck & 10K Form
Sell
48
MRK
Merck &
Last Price:
$83.15
Seasonality Move:
2.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-04-15 | 10K | MRK/Merck & Annual |
| 2025-03-15 | 10K | MRK/Merck & Annual |
| 2025-02-15 | 10K | MRK/Merck & Annual |
Receive MRK News And Ratings
See the #1 stock for the next 7 days that we like better than MRK
MRK Financial Statistics
Sales & Book Value
| Annual Sales: | $64.2B |
|---|---|
| Cash Flow: | $2.5B |
| Price / Cash Flow: | 11.21 |
| Annual Sales: | $18.32 |
| Price / Book: | 4.52 |
Profitability
| EPS (TTM): | 6.87000 |
|---|---|
| Net Income (TTM): | $17.4B |
| Gross Margin: | $49B |
| Return on Equity: | 40.25% |
| Return on Assets: | 15.39% |
Merck & Earnings Forecast
Key Merck & Financial Ratios
-
The Gross Profit Margin over the past 41 years for MRK is 76.32%.
-
The Selling, General & Administrative Expenses for MRK have been equal to 16.86% of Gross Profit Margin.
-
The Research & Development expenses have been 27.95% of Revenue.
-
The Interest Expense is 7.43% of Operating Income.
-
The Net Earning history of MRK is 26.68% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 25 years.
Merck & Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MRK |
| CUSIP: | 58933Y |
| Website: | merck.com |
Debt
| Debt-to-Equity Ratio: | 0.8 |
|---|---|
| Current Ratio: | 1.36 |
| Quick Ratio: | 0.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.34 |
|---|---|
| Forward P/E Ratio: | 8.52 |